Company
Headquarters: Mexico City, DF, Mexico
Employees: 2,221
MX$16.03 Billion
MXN as of July 1, 2024
US$872.4 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Genomma Lab Internacional, S.A.B. de C.V. together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico, the United States, and Latin America. It offers skin care products under the Cicatricure, Asepxia, and Teatrical brands; hair care products under the Vanart, Medicasp, Tío Nacho, and Sistema GB brands; razor products under the Groomen brand; hydrating beverage under the Suerox brand; and nutritional products for child under the Novamil brand. The company also provides pain relief products under the Alliviax brand; cough and cold medicines under the Tukol and Next brands; and antibacterial products under the Bufferin, XL-3, and Next-AB brands. In addition, it offers HIV diagnosis product under the OraQuick brand. Genomma Lab Internacional, S.A.B. de C.V. was founded in 1996 and is based in Mexico City, Mexico.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Genomma Lab Internacional, S.A.B. de C.V. has the following listings and related stock indices.
Stock: BMV: LABB wb_incandescent
Stock: FSX: GEKA wb_incandescent